The latest news for pharma industry insiders.
From Prescription to Patient: Four Ways to Increase Speed to Therapy
The key strategies for reducing or eliminating post-prescription abandonment.
What Does the End of DEI Mean For SDOH efforts?
The end of federal diversity, equity and inclusion programs in the federal government may have a ripple effect on social determinants of health efforts.
Drug Tariffs Will Harm Patients, AstraZeneca Chairman Says
Tariffs on pharmaceuticals would hurt patients and drugs should be exempt from these levies, AstraZeneca Plc’ Chairman Michel Demaré said.
Personalized Medicine Market Forecast Report and Company Analysis 2025-2033
The "Personalized Medicine Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's offering. The market is expected to reach US $1 trillion by 2033 from US $546.97 billion in 2024, with a CAGR of 7.05% from 2025 to 2033.
Hyfe's CEO Tamsin Chislett recently spoke to Pharmaceutical Executive about our work to bring digital therapeutics to the frontlines of chronic cough treatment.
We’re thrilled to be featured, and even more excited about what’s ahead.
👀 Curious? Catch the full story here: https://lnkd.in/d2RQNkwR
Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs